Epidemiology, definitions and classification

Vitiligo

Volumn , Issue , 2010, Pages 13-24

  Taïeb, Alain ^b   Picardo, Mauro ^a  

^a SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

^b HÔPITAL SAINT ANDRÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79955767695     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-540-69361-1_2     Document Type: Chapter

References (36)

1. Alkhateeb A, Fain PR, Thody A et al (2003) Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res 16:208-214
2. Bach JF (2002) The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 347:911-920
3. Berger TG, Kiesewetter F, Maczek C et al (2006) Psoriasis confined strictly to vitiligo areas - a Koebner-like phenomenon? J Eur Acad Dermatol Venereol 20:178-183
4. Boisseau-Garsaud AM, Garsaud P, Calès-Quist D et al (2000) Epidemiology of vitiligo in the French West Indies (Isle of Martinique). Int J Dermatol 39:18-20
5. Boissy RE, Manga P (2004) On the etiology of contact/occupational vitiligo. Pigment Cell Res 17:208-214
6. Brandrup F, Holm N, Grunnet N et al (1982) Psoriasis in monozygotic twins: variations in expression in individuals with identical genetic constitution. Acta Derm Venereol 62:229-236
7. Cario-André M, Ardilouze L, Pain C et al (2006) Imatinib mesilate inhibits melanogenesis in vitro. Br J Dermatol 155:493-494
8. Das SK, Majumder PP, Chakraborty R et al (1985) Studies on vitiligo. I. Epidemiological profile in Calcutta, India. Genet Epidemiol 2:71-78
9. Duffy DL, Spelman LS, Martin NG (1993) Psoriasis in Australian twins. J Am Acad Dermatol 29:428-434
10. De Vijlder HC, Westerhof W, Schreuder GM et al (2004) Difference in pathogenesis between vitiligo vulgaris and halo nevi associated with vitiligo is supported by an HLA association study. Pigment Cell Res 17:270-274
11. Gauthier Y, Cario-Andre M, Taieb A (2003) A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy? Pigment Cell Res 16:322-332
12. Gogas H, Ioannovich J, Dafni U et al (2006) Prognostic significance of autoimmunity during treatment of melanoma with interferon. N Engl J Med 354:709-718
13. Guillet G, Helenon R, Gauthier Y et al (1988) Progressive macular hypomelanosis of the trunk: primary acquired hypopigmentation. J Cutan Pathol 15:286-289
14. Hann SK, Lee HJ (1996) Segmental vitiligo: clinical findings in 208 patients. J Am Acad Dermatol 35:671-674
15. Hartmann A, Bedenk C, Keikavoussi P et al (2008) Vitiligo and melanoma-associated hypopigmentation (MAH): shared and discriminative features. J Dtsch Dermatol Ges 6:1053-1059
16. Howitz J, Brodthagen H, Schwartz M et al (1977) Prevalence of vitiligo: epidemiological survey on the Isle of Bornholm, Denmark. Arch Dermatol 113:47-52
17. Kim YC, Kim YJ, Kang HY et al (2008) Histopathologic features in vitiligo. Am J Dermatopathol 30:112-116
18. Koga M (1977) Vitiligo: a new classification and therapy. Br J Dermatol 97:255-261
19. Kumarasinghe SP, Tan SH, Thng S et al (2006) Progressive macular hypomelanosis in Singapore: a clinico-pathological study. Int J Dermatol 45:737-742
20. Lee HS, Chun YS, Hann SK (1999) Nevus depigmentosus: clinical features and histopathologic characteristics in 67 patients. J Am Acad Dermatol 40:21-26
21. Liu JB, Li M, Yang S et al (2005) Clinical profiles of vitiligo in China: an analysis of 3742 patients. Clin Exp Dermatol 30:327-331
22. Mashiah J, Brenner S (2008) Possible mechanisms in the induction of vitiligo-like hypopigmentation by topical imiquimod. Clin Exp Dermatol 33:74-76
23. Mulekar SV, Al Issa A, Asaad M et al (2006) Mixed vitiligo. J Cutan Med Surg 10:104-107
24. Oplatek A, Brown K, Sen S, et al (2006) Long-term followup of patients treated for toxic epidermal necrolysis. J Burn Care Res 27:26-33
25. Relyveld GN, Dingemans KP, Menke HE et al (2008) Ultrastructural findings in progressive macular hypomelanosis indicate decreased melanin production. J Eur Acad Dermatol Venereol 22:568-574
26. Schallreuter KU, Krüger C, Rokos H et al (2007) Basic research confirms coexistence of acquired Blaschkolinear Vitiligo and acrofacial Vitiligo. Arch Dermatol Res 299:225-230
27. Schallreuter KU, Krüger C, Würfel BA et al (2008) From basic research to the bedside: efficacy of topical treatment with pseudocatalase PC-KUS in 71 children with vitiligo. Int J Dermatol 47:743-753
28. Schultz Larsen F (1993) Atopic dermatitis: a genetic-epidemiologic study in a population-based twin sample. J Am Acad Dermatol 28:719-723
29. Sehgal VN, Srivastava G (2007) Vitiligo: compendium of clinico-epidemiological features. Indian J Dermatol Venereol Leprol 73:149-156
30. Singh M, Singh G, Kanwar AJ, Belhaj MS (1985) Clinical pattern of vitiligo in Libya. Int J Dermatol 24:233-235
31. Singh ZN, Tretiakova MS, Shea CR, Petronic-Rosic VM (2006) Decreased CD117 expression in hypopigmented mycosis fungoides correlates with hypomelanosis: lessons learned from vitiligo. Mod Pathol 19:1255-1260
32. Smith DA, Burgdorf WH (1984) Universal cutaneous depigmentation following phenytoin-induced toxic epidermal necrolysis. J Am Acad Dermatol 10:106-109
33. Spritz RA (2007) The genetics of generalized vitiligo and associated autoimmune diseases. Pigment Cell Res 20:271-278
34. Taïeb A, Picardo M; VETF Members (2007) The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res 20:27-35
35. Thoma W, Krämer HJ, Mayser P (2005) Pityriasis versicolor alba. J Eur Acad Dermatol Venereol 19:147-152
36. Westerhof W, Relyveld GN, Kingswijk MM et al (2004) Propionibacterium acnes and the pathogenesis of progressive macular hypomelanosis. Arch Dermatol 140:210-214